COVID-19 Variants & Disease Variability

This white paper explores SARS-CoV-2 variants, disease progression, and biomarker discovery to better understand COVID-19 variability and severity. It outlines the different clinical stages of infection, from mild to critical illness, and highlights key biomarkers associated with disease outcomes, including inflammatory and immune response markers. The study also reviews current therapeutic strategies and emphasizes the importance of genomic and proteomic analysis in advancing COVID-19 diagnostics, patient stratification, and treatment development.